RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use

NACompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2023

Conditions
Opioid UseArthropathy of KneePain, Postoperative
Interventions
DEVICE

RelieVRx headset

RelieVRx is a virtual reality therapy intended as adjunctive treatment for acute surgical pain

DRUG

multi-modality pain management

combination of medications may be used such as a local anesthesia, ibuprofen, acetaminophen, gabapentin, ketamine, lidocaine, and opioids

Trial Locations (3)

17822

Geisinger Medical Center, Danville

18711

Geisinger Wyoming Valley Medical Center, Wilkes-Barre

18765

Geisinger South Wilkes Barre, Wilkes-Barre

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Geisinger Clinic

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

AppliedVR Inc.

INDUSTRY